Median OS for patients with metastatic breast cancer is highly variable according to tumor subtype, ranging from ~18 months for triple-negative breast cancer to ~5 years for hormone receptor positive/HER2-negative breast cancer. Several new treatment options have recently emerged that are expected to improve median survival of newly diagnosed patients in the next decade.
For additional information, refer to the National Comprehensive Cancer Network (NCCN) Breast Cancer Clinical Practice Guidelines and the European Society for Medical Oncology (ESMO) Clinical Practice Guideline for diagnosis, staging, and treatment of patients with metastatic breast cancer.
Learn more about the optimal management of metastatic breast cancer.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer? - Medscape - Dec 15, 2022.